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We tested the effect of the cardioactive peptide Urocortin 2 (Ucn2; 100 nM)
on action potential (AP)-induced Ca transients (CaT), sarcoplasmic reticulum
(SR) Ca load and cardiac Ca alternans. Experiments were performed on single
rabbit atrial and ventricular myocytes from normal and failing hearts. Chronic
heart failure (HF) was induced by combined pressure- and volume-overload.
Ca and mechanical alternans was induced by electrical pacing. Changes in
cytosolic [Ca]i and [Ca]SR were monitored with fluorescent indicators, in
conjunction with sarcomere length measurements. The average Ca alternans
ratio (AR ¼ 1-S/L; S: small amplitude CaT; L: large-amplitude CaT) was
0.51 in normal atrial myocytes, and 0.43 and 0.53 in normal and HF ventric-
ular myocytes, respectively. Ucn2 increased SR Ca load in normal, and to a
larger degree in HF ventricular cells, and enhanced AP-induced SR Ca deple-
tion transients. Baseline phosphorylation levels of phospholamban (PLN) at
Ser16 were increased in HF myocytes, and Ucn2 stimulation further
augmented PLN phosphorylation in normal myocytes (~10-fold) and to a
lesser extent (~5-fold) in HF ventricular myocytes. Ucn2 completely abol-
ished Ca and mechanical alternans (within 2-3 min) in normal atrial as well
as in normal and HF ventricular myocytes. In the presence of Astressin-2B
(1 mM; inhibition of corticotropin-releasing factor receptor; CRFR2) and
H89 (1 mM; protein kinase A inhibition) Ucn2 failed to rescue alternans. In
conclusion, we propose that Ucn2 rescues cardiac alternans via CRFR2-
mediated stimulation of PKA, phosphorylation of PLN and enhanced cyto-
solic Ca sequestration by SERCA.
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Background: Loss of function mutations in hERG potassium channels underlie
the long QT syndrome type 2 (LQT2). LQT2 is associated with fatal ventricular
arrhythmias promoted by triggered activity in the form of early afterdepolari-
zations (EADs). However, the cellular mechanism of EAD formation remains
unexplored.
Methods: We have investigated the mechanism of EAD formation in LQT2
ventricular myocytes using a physiologically detailed computational model
of calcium (Ca2þ) cycling and membrane voltage dynamics. This model
bridges the submicron scale of individual couplons of plasmalemmal L-type
Ca2þ channels clusters and sarcoplasmic reticulum (SR) Ca2þ release units
(CRUs) and the whole cell. We incorporate the novel experimental finding
that ryanodine receptors (RyRs) Ca2þ release channels are remodeled in ven-
tricular mycoytes isolated from LQT2 transgenic rabbits; RyRs are hyper-
phosphorylated leading to enhanced channel activity and hence increased
Ca2þ leak.
Results: Computer simulations with RyR hyperactivity modeled as an
increased rate of channel opening show that hyperactivity is causally linked
to EAD formation. Under stimulation with the b-adrenergic agonist isoproter-
enol (ISO), LQT2myocytes with hyperactive RyRs exhibit EADs together with
decreased SR load and Ca2þ transient (CaT) amplitude, while myocytes with
normal RyR activity exhibit a prolonged action potential without reductions
of SR load and CaT amplitude. Simulations show that RyR hyperactivity
shortens RyR refractoriness at the CRU level, resulting in late aberrant Ca2þ
releases during repolarization. Those releases promote onset of EADs by
driving the forward mode Naþ-Ca2þ exchanger NCX1 current, which slows
repolarization and allows reactivation of L-type Ca2þ current. Modeling pre-
dictions are in good agreement with experimental observations, which show
that EADs in ISO-stimulated LQT2 myocytes are accompanied by late Ca2þ
releases together with decreased SR load and CaT amplitude, and that both
late releases and EADs are abolished by inhibition of CaMKII.1335-Pos Board B286
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Spontaneous calcium (Ca) release in cardiac myocytes can produce delayed
afterdepolarizations (DADs) that promote arrhythmias. In these studies, we
combined experimental and computational approaches to investigate quantita-
tively how Ca release features at subcellular, cellular, and tissue scales influ-
ence DADs. Spontaneous Ca release events and corresponding DADs were
measured experimentally from isolated rabbit ventricular myocytes exposed
to elevated extracellular Ca (2.7 mM) and isoproterenol (0.25 mM), and were
compared between lower and higher total intracellular Ca levels following 1
or 5 paced beats at 400 ms intervals, respectively. At the subcellular scale,
Ca waves emerged simultaneously from an average of 1.36 (low) and 2.5
(high) sites per Ca release event. Consistent with the criticality-based theory
of Ca wave emergence, Ca wave numbers were proportional to sarcoplasmic
reticulum (SR) Ca levels that produced INCX with 71.1 pA/pFms (low)
and 106.0 pA/pFms (high) integrated current densities upon rapid exposure
to caffeine (10 mM). At the cellular scale, whole-cell calcium transients had
peak amplitudes of 0.462 F/Fo (low) and 0.717 F/Fo (high) and full widths
at half maximum (FWHMs) of 309.0 ms (low) and 180.0 ms (high). Resultant
DADs had peak amplitudes of 1.41 mV (low) and 6.03 mV (high) and FWHMs
of 302.3 ms (low) and 140.3 ms (high). Ca wave latencies in single myocytes,
which determine Ca release synchrony in cardiac tissue, were 0.996 s (low) and
0.416 s (high). Computer simulation analyses implementing various combina-
tions of the experimentally measured factors suggest that greater numbers of Ca
waves, increased SR Ca release, and greater synchrony are associated with
larger DAD amplitudes in cardiac tissue. Simulations also suggest that the sub-
cellular number of Ca waves has the largest impact on DAD amplitude in
tissue.
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Using fluorescence resonance energy transfer (FRET), we directly tested the
hypothesis that S100A1 competes with calmodulin (CaM) for binding to
intact, functional ryanodine receptors type I (RyR1) and II (RyR2) from
skeletal and cardiac muscle, respectively. This hypothesis is largely based
on competition assays using isolated sarcoplasmic reticulum (SR) mem-
branes from skeletal muscle and evidence that S100A1 binds to peptides cor-
responding to one of the proposed CaM binding domains on RyR1.
However, competition between S100A1 and CaM for RyR binding has not
been directly detected. We targeted a donor-labeled FKBP12.6 (D-FKBP)
to the cytoplasmic domain of RyR1 or RyR2 in SR vesicles isolated from
pig skeletal or cardiac muscle. FRET was detected as a decrease of
D-FKBP fluorescence in the presence of 100nM acceptor-labeled CaM
(A-CaM) and used to index CaM binding to RyR. Upon pre-incubating SR
with [S100A1] ranging from 0.01 to >100 mM, we found partial inhibition
of FRET, with mM KI, for both skeletal and cardiac SR. By comparison,
FRET was completely inhibited by unlabeled WT-CaM (KI ~100nM), indi-
cating that A-CaM and WT-CaM bind RyR with similar affinities and at the
same site. Similar results were obtained using co-sedimentation assays con-
ducted under similar experimental conditions, to detect competition between
S100A1 and CaM binding to SR membranes. Taken together, these results
indicate that CaM-RyR binding may not be significantly competed by
S100A1 under normal physiologic conditions. Furthermore, structural anal-
ysis of FRET data suggests that S100A1 allosterically interacts with RyR-
CaM binding. Initial results from a complementary FRET approach, using
acceptor-labeled S100A1, further support the conclusion that S100A1 does
not significantly compete with CaM-RyR binding in skeletal or cardiac
muscle.
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